banner
updates.chemo.org.uk
@updates.chemo.org.uk
🤖 Automated message

NHS England has updated the Cancer Drugs Fund List to version 1.386.

https://updates.chemo.org.uk/news/CDFNews_1.386.html

Changes - 👇 🧵
NHS England updates CDF List – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
February 12, 2026 at 6:03 PM
🤖 Automated message

4 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2026-02-12.html

Changes: nivolumab, amivantamab, alpelisib
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
February 12, 2026 at 3:23 PM
🤖 Automated message

4 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2026-02-09.html

Changes: amivantamab, abiraterone acetate, nivolumab
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
February 9, 2026 at 3:23 PM
🤖 Automated message

16 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2026-02-05.html

Changes: paclitaxel albumin, entrectinib, vandetanib, Bosutinib, vedolizumab, upadacitinib hemihydrate,...
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
February 5, 2026 at 3:23 PM
🤖 Automated message

13 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2026-02-02.html

Changes: fluorouracil, abemaciclib, selpercatinib, blinatumomab, epcoritamab, melphalan hydrochloride, ...
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
February 2, 2026 at 3:23 PM
🤖 Automated message

5 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2026-01-29.html

Changes: talquetamab, encorafenib, plerixafor, fluorouracil
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
January 29, 2026 at 3:23 PM
🤖 Automated message

NHS England has updated the Cancer Drugs Fund List to version 1.381.

https://updates.chemo.org.uk/news/CDFNews_1.381.html

Changes - 👇 🧵
NHS England updates CDF List – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
January 27, 2026 at 8:05 PM
🤖 Automated message

NHS England has updated the Cancer Drugs Fund List to version 1.380.

https://updates.chemo.org.uk/news/CDFNews_1.380.html

Changes - 👇 🧵
NHS England updates CDF List – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
January 27, 2026 at 7:48 PM
🤖 Automated message

8 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2026-01-26.html

Changes: belantamab mafodotin, mycophenolic acid as mycophenolate sodium, bacillus calmette-guerin, enco...
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
January 26, 2026 at 3:23 PM
🤖 Automated message

18 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2026-01-22.html

Changes: atezolizumab, lorlatinib, Tarlatamab, bortezomib mannitol boronic ester, apremilast, nilotinib...
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
January 22, 2026 at 3:23 PM
🤖 Automated message

7 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2026-01-19.html

Changes: brexucabtagene autoleucel, binimetinib, axicabtagene ciloleucel, atezolizumab
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
January 19, 2026 at 3:23 PM
🤖 Automated message

5 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2026-01-15.html

Changes: Lisocabtagene maraleucel, pembrolizumab, ropeginterferon alfa-2b, brexucabtagene autoleucel, bi...
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
January 15, 2026 at 3:23 PM
🤖 Automated message

6 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2026-01-12.html

Changes: abemaciclib, trastuzumab, belumosudil mesilate, Lisocabtagene maraleucel, pembrolizumab
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
January 12, 2026 at 3:23 PM
🤖 Automated message

8 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2026-01-08.html

Changes: obinutuzumab, sacituzumab govitecan, fedratinib dihydrochloride monohydrate, imlifidase, abemac...
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
January 8, 2026 at 3:23 PM
🤖 Automated message

6 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2026-01-05.html

Changes: mycophenolate mofetil, paclitaxel albumin, talquetamab, obinutuzumab, sacituzumab govitecan
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
January 5, 2026 at 3:23 PM
🤖 Automated message

31 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2026-01-01.html

Changes: cyclophosphamide, durvalumab, methotrexate, nivolumab, axicabtagene ciloleucel, methotrexate d...
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
January 1, 2026 at 3:23 PM
🤖 Automated message

11 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2025-12-22.html

Changes: trastuzumab, isatuximab, Mirvetuximab soravtansine, cisplatin, thiotepa, brexucabtagene autole...
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
December 22, 2025 at 3:23 PM
🤖 Automated message

9 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2025-12-18.html

Changes: trastuzumab, capivasertib, olaparib, pentostatin, pembrolizumab, ciltacabtagene autoleucel, Mir...
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
December 18, 2025 at 3:23 PM
🤖 Automated message

8 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2025-12-15.html

Changes: daratumumab, acalabrutinib maleate, bevacizumab, Futibatinib, capivasertib, trastuzumab
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
December 15, 2025 at 3:23 PM
🤖 Automated message

5 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2025-12-11.html

Changes: osimertinib mesylate, cemiplimab, daratumumab, acalabrutinib maleate
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
December 11, 2025 at 3:23 PM
🤖 Automated message

5 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2025-12-08.html

Changes: imatinib mesilate, azathioprine, eculizumab, osimertinib mesylate, cemiplimab
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
December 8, 2025 at 3:23 PM
🤖 Automated message

6 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2025-12-04.html

Changes: dinutuximab beta, apremilast, imatinib mesilate, azathioprine
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
December 4, 2025 at 3:23 PM
🤖 Automated message

7 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2025-12-01.html

Changes: afatinib dimaleate, ibrutinib, dinutuximab beta, apremilast
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
December 1, 2025 at 3:23 PM
🤖 Automated message

4 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2025-11-27.html

Changes: ciltacabtagene autoleucel, afatinib dimaleate, ibrutinib
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
November 27, 2025 at 3:23 PM
🤖 Automated message

NHS England has updated the Cancer Drugs Fund List to version 1.379.

https://updates.chemo.org.uk/news/CDFNews_1.379.html

Changes - 👇 🧵
NHS England updates CDF List – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
November 26, 2025 at 6:01 PM